ARDS was underrecognized in the study population across all body mass indexesBMIs, but this underrecognition did not explain why patients with class 3 obesity were more likely to meet ARDS criteria but not receive low tidal volume ventilation.
Twice-daily ensifentrine was associated with improvements in several symptoms of COPD, including breathlessness, chest symptoms, cough and sputum, and shortness of breath.
Clinical experts in pulmonary arterial hypertension (PAH) identified certain hemodynamic variables as predictive of patient survival that were different from variables found in major clinical trials.
Twice-daily selexipag was associated with improvements in 6-minute walk distance and potential maintenance or improvement in World Health Organization functional class in patients with pulmonary arterial hypertension.
Metformin was effective in reducing pulmonary fibrosis in human IPF fibroblasts and when used in combination with low-dose nintedanib, demonstrated a synergistic, antifibrotic effect.
Obstructive sleep apnea increases left ventricular hypertrophy in patients with treatment-resistant hypertension.
Proton pump inhibitors have demonstrated efficacy in reducing gastrointestinal bleeding without an increased risk for infection among patients in critical care.
A typical usual interstitial pneumonia pattern was the predominant radiologic pattern seen in patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension.